PARIS--(BUSINESS WIRE)-- STEM-Pharma is a management consulting firm specialized in healthcare and pharmaceutical market intelligence. The company delivers evidence-based recommendations on pharmaceutical growth opportunities in emerging markets. Supported by the company’s proprietary economic models, STEM-Pharma’s emerging market experts advise key stakeholders on targeted resource allocation and investment opportunities.
STEM-Pharma’s services include management consulting reports providing in-depth insight into the pharmaceutical industry in emerging markets, through a unique combination of economic, healthcare, and pharmaceutical analysis. STEM Pharma’s partners are provided with a clear roadmap for business growth in pharmaceutical Sales, Manufacturing, and R&D.
STEM-Pharma recently launched its website, www.stem-pharma.com, where detailed information about the company and its latest reports can be found. STEM-Pharma also connects with its partners through the different social media platforms.
STEM-Pharma aims at becoming a leader in health economic research and pharmaceutical consulting providing valuable guidance for investment decisions.